| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |